Morning Session - Clinical
problems, epidemiology & natural history
Natural history keynote talk
John Yates
Progress in the application of less invasive
therapeutic techniques to the management of renal lesions associated
with TSC
John Hulbert
TSC and renal AMLs: long term outcome in a case
series from a renal referral centre
Rosa Montero
The management of over 70 patients with tuberous
sclerosis and renal angiomyolipomata
Prasanna Sooriakumaran
Epidemiology keynote talk
Finbar O’Callaghan
Tuberous sclerosis 2000 study: early intellectual
development
Patrick Bolton
Prevalence of subependymal giant cell tumours in
patients with tuberous sclerosis and a review of the literature
Miraude Adriaensen
The TSC database: a valuable resource for the TSC
community
Rosemary Ekong
TSC Natural History Database
Vicky Whittemore
Afternoon Session - Clinical Trials
Keynote talk
John Bissler
Update on the US multi-centre
rapamycin angiomyolipoma trial and recent TSC preclinical studies
Sandra Dabora
Safety and efficacy of RAD001 (Everolimus) for the
treatment of subependymal giant cell astrocytoma in pediatric and
adult patients with TSC
Darcy Krueger
TESSTAL: a trial of the safety and efficacy of sirolimus (rapamycin)
therapy for renal angiomyolipomas in patients with tuberous sclerosis
complex or sporadic lymphangioleiomyomatosis
Mark Davies
Functional analysis of TSC1 and
TSC2 variants
Mark Nellist
Development of a xenograft model
using TSC2-null skin tumour cells from patients with tuberous
sclerosis
Shaowei Li
Manned Poster Session
TS2000 Meeting
(closed meeting)
Conference Dinner,
Gallery 1&2 |